← back to search

Ernst Lengyel

Health First · US
Area of research
Reproductive Medicine · Cancer Research
Research interest
Research interests include Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, MicroRNA in disease regulation, and Cancer, Lipids, and Metabolism.
h-index
72
citations
29,829
works
576
NIH funding
primary concept
Medicine
email

Recent publications

Radiation-induced amphiregulin drives tumour metastasis
Nature 2025cited by 56position: middledoi
Neutrophil extracellular traps promote pre-metastatic niche formation in the omentum by expanding innate-like B cells that express IL-10
Cancer Cell 2025cited by 40position: middledoi
NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity
Nature 2025cited by 28position: lastdoi
A cell atlas of the human fallopian tube throughout the menstrual cycle and menopause
Nature Communications 2025cited by 18position: middledoi
Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression
Cancer Cell 2025cited by 15position: lastdoi
LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarker
npj Precision Oncology 2025cited by 7position: middledoi
Metformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial
Gynecologic Oncology 2025cited by 7position: middledoi
Publisher Correction: Radiation-induced amphiregulin drives tumour metastasis
Nature 2025cited by 1position: middledoi
Molecular changes driving low-grade serous ovarian cancer and implications for treatment
International Journal of Gynecological Cancer 2024cited by 24position: lastdoi
5-Hydroxymethylcytosine signals in serum are a predictor of chemoresistance in high-grade serous ovarian cancer
Gynecologic Oncology 2024cited by 9position: lastdoi
Systematic treatment and management of postpartum hypertension using remote patient monitoring
Pregnancy Hypertension 2024cited by 9position: middledoi
Adipocytes reprogram cancer cell metabolism by diverting glucose towards glycerol-3-phosphate thereby promoting metastasis
Nature Metabolism 2023cited by 57position: lastdoi
Cancer-associated mesothelial cell–derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis
JCI Insight 2023cited by 46position: middledoi
The glycoprotein CD147 defines miRNA‐enriched extracellular vesicles that derive from cancer cells
Journal of Extracellular Vesicles 2023cited by 34position: middledoi
Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort
JAMA Network Open 2023cited by 25position: lastdoi
Understanding Long-Term Survival of Patients with Ovarian Cancer—The Tumor Microenvironment Comes to the Forefront
Cancer Research 2023cited by 15position: lastdoi
Deep Visual Proteomics defines single-cell identity and heterogeneity
Nature Biotechnology 2022cited by 518position: middledoi
The adipocyte microenvironment and cancer
Cancer and Metastasis Reviews 2022cited by 169position: lastdoi
A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing
Cell Reports 2022cited by 69position: firstdoi
Resilience in the Face of Pandemic: The Impact of COVID-19 on the Psychologic Morbidity and Health-Related Quality of Life Among Women With Ovarian Cancer
JCO Oncology Practice 2022cited by 21position: middledoi
Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis
Cell 2021cited by 361position: middledoi
Change in Health-Related Socioeconomic Risk Factors and Mental Health During the Early Phase of the COVID-19 Pandemic: A National Survey of U.S. Women
Journal of Women s Health 2021cited by 66position: lastdoi
The Natural Product β-Escin Targets Cancer and Stromal Cells of the Tumor Microenvironment to Inhibit Ovarian Cancer Metastasis
Cancers 2021cited by 25position: lastdoi
The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer
Cancer Research 2021cited by 21position: middledoi
The Effects of Chemotherapeutics on the Ovarian Cancer Microenvironment
Cancers 2021cited by 19position: lastdoi
Germline mutations in Black patients with ovarian, fallopian tube and primary peritoneal carcinomas
Gynecologic Oncology 2021cited by 18position: middledoi
Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment
Obstetrics and Gynecology 2020cited by 336position: lastdoi
Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance
Cancer Research 2020cited by 304position: lastdoi
A streamlined mass spectrometry–based proteomics workflow for large‐scale FFPE tissue analysis
The Journal of Pathology 2020cited by 188position: middledoi
Deconstructing tumor heterogeneity: the stromal perspective
Oncotarget 2020cited by 42position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hilary A. Kenny · Robert H. Lurie Comprehensive Cancer Center of Northwestern University19 papers (2013–2023)Iris L. Romero · University of Chicago13 papers (2013–2025)Mark A. Eckert · University of Chicago12 papers (2015–2022)Ricardo R. Lastra · University of Chicago11 papers (2016–2025)Abir Mukherjee · University of Chicago10 papers (2014–2023)S. Diane Yamada · Gynecologic Oncology Group10 papers (2014–2019)Marion Curtis · WinnMed7 papers (2015–2019)Melanie Weigert · University of Chicago7 papers (2019–2025)Anthony Montag · University of Chicago7 papers (2014–2019)Anirban Mitra · Indiana University Health7 papers (2012–2018)Kristen Wroblewski · Chicago Department of Public Health7 papers (2014–2023)Chun-yi Chiang · University of Chicago6 papers (2014–2023) · 6 papers (2012–2025)Lacey M. Litchfield · Eli Lilly (United States)6 papers (2014–2019)Fabian Coscia · University of Copenhagen6 papers (2016–2022)Matthias Mann · Novo Nordisk Foundation6 papers (2016–2022)Yilin Zhang · Soochow University6 papers (2013–2018) · 6 papers (2012–2025)Gini F. Fleming · Sydney Local Health District5 papers (2015–2025)Marcus E. Peter · Northwestern University5 papers (2012–2021)